These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22145998)

  • 1. Relapsing insulin-induced lipoatrophy, cured by prolonged low-dose oral prednisone: a case report.
    Chantelau EA; Praetor R; Praetor J; Poll LW
    Diabetol Metab Syndr; 2011 Dec; 3(1):33. PubMed ID: 22145998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-induced localized lipoatrophy preceded by shingles (herpes zoster): a case report.
    Chantelau EA; Prätor R; Prätor J
    J Med Case Rep; 2014 Jun; 8():223. PubMed ID: 24961832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoatrophy associated with rapid-acting insulin analogues in young patients with type 1 diabetes mellitus.
    Szypowska A; Skórka A; Pańkowska E
    Pediatr Endocrinol Diabetes Metab; 2008; 14(2):117-8. PubMed ID: 18721499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-induced Lipoatrophy in a Patient on Insulin Analogue Therapy: a Case Report.
    Yanachkova V; Staynova R
    Folia Med (Plovdiv); 2020 Sep; 62(3):597-600. PubMed ID: 33009748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Humalog® 200 U/ml KwikPen™].
    Scheen AJ
    Rev Med Liege; 2015 Oct; 70(10):527-31. PubMed ID: 26727843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoatrophy with insulin analogues in type I diabetes.
    Babiker A; Datta V
    Arch Dis Child; 2011 Jan; 96(1):101-2. PubMed ID: 20570843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoatrophy induced by recombinant human insulin injection.
    Murao S; Hirata K; Ishida T; Takahara J
    Intern Med; 1998 Dec; 37(12):1031-3. PubMed ID: 9932635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog
    Leohr J; Dellva MA; Coutant DE; LaBell E; Heise T; Andersen G; Zijlstra E; Hermanski L; Nosek L; Linnebjerg H
    Clin Pharmacokinet; 2020 Dec; 59(12):1601-1610. PubMed ID: 32468448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compatibility and Safety of Ultra Rapid Lispro with Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: PRONTO-Pump Study.
    Bode BW; Garg SK; Norwood P; Morales C; Hardy T; Liu R; Ignaut D
    Diabetes Technol Ther; 2021 Jan; 23(1):41-50. PubMed ID: 32640842
    [No Abstract]   [Full Text] [Related]  

  • 10. Detemir plus aspart and glulisine induced lipoatrophy: 2015 literature review and report of a new case.
    Saberi S; Esfandiari NH; MacEachern MP; Tan MH
    Clin Diabetes Endocrinol; 2015; 1():10. PubMed ID: 28702229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous subcutaneous insulin infusion allows tolerance induction and diabetes treatment in a type 1 diabetic child with insulin allergy.
    Hasselmann C; Pecquet C; Bismuth E; Raverdy C; Sola-Gazagnes A; Lobut JB; Carel JC; Tubiana-Rufi N
    Diabetes Metab; 2013 Apr; 39(2):174-7. PubMed ID: 23206896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human insulin-induced lipoatrophy. Successful treatment using a jet-injection device.
    Logwin S; Conget I; Jansa M; Vidal M; Nicolau C; Gomis R
    Diabetes Care; 1996 Mar; 19(3):255-6. PubMed ID: 8742573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs.
    Radermecker RP; Piérard GE; Scheen AJ
    Am J Clin Dermatol; 2007; 8(1):21-8. PubMed ID: 17298103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin allergy and extensive lipoatrophy in child with type 1 diabetes.
    Beltrand J; Guilmin-Crepon S; Castanet M; Peuchmaur M; Czernichow P; Levy-Marchal C
    Horm Res; 2006; 65(5):253-60. PubMed ID: 16582568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog
    Linnebjerg H; Zhang Q; LaBell E; Dellva MA; Coutant DE; Hövelmann U; Plum-Mörschel L; Herbrand T; Leohr J
    Clin Pharmacokinet; 2020 Dec; 59(12):1589-1599. PubMed ID: 32468447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of lipoatrophy with insulin detemir.
    Del Olmo MI; Campos V; Abellán P; Merino-Torres JF; Piñón F
    Diabetes Res Clin Pract; 2008 Apr; 80(1):e20-1. PubMed ID: 18281121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergy to insulin in a woman with gestational diabetes mellitus: transient efficiency of continuous subcutaneous insulin lispro infusion.
    Durand-Gonzalez KN; Guillausseau N; Anciaux ML; Hentschel V; Gayno JP
    Diabetes Metab; 2003 Sep; 29(4 Pt 1):432-4. PubMed ID: 14526273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin-related complications of insulin therapy: epidemiology and emerging management strategies.
    Richardson T; Kerr D
    Am J Clin Dermatol; 2003; 4(10):661-7. PubMed ID: 14507228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Insulin-induced lipoatrophy in children].
    Niinikoski H; Näntö-Salonen K; Ruusu P; Kinnala A; Putto-Laurila A; Toppari J; Keskinen P
    Duodecim; 2010; 126(11):1328-32. PubMed ID: 20681357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoatrophy associated with the use of insulin analogues: a new case associated with the use of insulin glargine and review of the literature.
    Holstein A; Stege H; Kovacs P
    Expert Opin Drug Saf; 2010 Mar; 9(2):225-31. PubMed ID: 20001763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.